Jazz Pharmaceuticals plc Interest Expense
Jazz Pharmaceuticals plc (JAZZ) reported Interest Expense of $58.00 thousand for the 3-month period ending 2012-03-31, per its 10-Q filed 2012-05-08.
Discontinued › Expense Statement › Interest Expense
us-gaap:InterestExpense · last filed 2012-05-08
- Jazz Pharmaceuticals plc interest expense for the quarter ending 2012-03-31 was $58.00K, a 92.54% decline year-over-year.
- Jazz Pharmaceuticals plc interest expense for the quarter ending 2011-12-31 was $110.00K, a 89.79% decline year-over-year.
- Jazz Pharmaceuticals plc interest expense for the quarter ending 2011-09-30 was $129.00K, a 89.22% decline year-over-year.
- Jazz Pharmaceuticals plc interest expense for the quarter ending 2011-06-30 was $659.00K, a 85.94% decline year-over-year.
- Jazz Pharmaceuticals plc interest expense for fiscal 2011 was $1.68M, a 86.84% decline from fiscal 2010.
- Jazz Pharmaceuticals plc interest expense for fiscal 2010 was $12.73M, a 44.17% decline from fiscal 2009.
- Jazz Pharmaceuticals plc interest expense for fiscal 2009 was $22.80M.
| Period end | Interest Expense 3 month | Interest Expense 6 month | Interest Expense 9 month | Interest Expense 12 month |
|---|---|---|---|---|
| 2012-03-31 | $58.00K 10-Q · filed 2012-05-08 | $168.00K derived: sum of 2 quarters · filed 2012-05-08 | $297.00K derived: sum of 3 quarters · filed 2012-05-08 | $956.00K derived: sum of 4 quarters · filed 2012-05-08 |
| 2011-12-31 | $110.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-28 | $239.00K derived: sum of 2 quarters · filed 2012-02-28 | $898.00K derived: sum of 3 quarters · filed 2012-02-28 | $1.68M 10-K · filed 2012-02-28 |
| 2011-09-30 | $129.00K 10-Q · filed 2011-11-08 | $788.00K derived: sum of 2 quarters · filed 2011-11-08 | $1.56M 10-Q · filed 2011-11-08 | $2.64M derived: sum of 4 quarters · filed 2012-05-08 |
| 2011-06-30 | $659.00K 10-Q · filed 2011-08-03 | $1.44M 10-Q · filed 2011-08-03 | $2.51M derived: sum of 3 quarters · filed 2012-05-08 | $3.71M derived: sum of 4 quarters · filed 2012-05-08 |
| 2011-03-31 | $777.00K 10-Q · filed 2012-05-08 | $1.85M derived: sum of 2 quarters · filed 2012-05-08 | $3.05M derived: sum of 3 quarters · filed 2012-05-08 | $7.74M derived: sum of 4 quarters · filed 2012-05-08 |
| 2010-12-31 | $1.08M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-28 | $2.27M derived: sum of 2 quarters · filed 2012-02-28 | $6.96M derived: sum of 3 quarters · filed 2012-02-28 | $12.73M 10-K · filed 2012-02-28 |
| 2010-09-30 | $1.20M 10-Q · filed 2011-11-08 | $5.88M derived: sum of 2 quarters · filed 2011-11-08 | $11.65M 10-Q · filed 2011-11-08 | |
| 2010-06-30 | $4.69M 10-Q · filed 2011-08-03 | $10.45M 10-Q · filed 2011-08-03 | ||
| 2009-12-31 | $22.80M 10-K · filed 2012-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |